E-drug: Meeting statement queries on cost effectiveness (cont'd)
---------------------------------------------
I have read with interest the meeting statement of 23 and 24 March
about reducing HIV transmission from mothers to their children. In
that statement there is a sentence "Recent cost-effectiveness data
suggest that in many developing countries this intervention is
comparable to other public health interventions." I may have been
travelling and have missed this data. Is anyone aware of what studies
they are referring to.
What prices are being used to calculate drug or HIV testing kit costs?
It would be good to see this data as I think there are far more cost
effective ways of preventing HIV transmission.
Richard Laing
Richard Laing M.B. Ch.B. M.Sc. M.D. Tel 1-617-414-1444
Associate Professor, Fax 1-617-638-4476
Department of International Health,
Boston University School of Public Health,
715 Albany Street, T4W
Boston MA 02118 USA
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.